Alik Farber, MD
James Utley Professor and Chair of Surgery
Boston University Chobanian & Avedisian School of Medicine

MD, Harvard Medical School
MBA, Brandeis University
BS, Brown University



Dr. Alik Farber is the Surgeon-in-Chief at BMC. He is also the James Utley Professor and Chair of Surgery at Boston University Chobanian & Avedisian School of Medicine.

Dr. Farber is an expert in vascular and endovascular intervention to treat peripheral arterial disease, open and endovascular abdominal and thoracic aortic aneurysm repair, the treatment of diabetic foot problems, carotid artery surgery and stenting, and dialysis access. He is a prolific researcher who has published more than 260 peer-reviewed articles and has served as a principal investigator (PI) for a number of clinical trials, including the recently completed BEST-CLI (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia) trial. Dr. Farber was a national PI for this international, randomized controlled trial.

Dr. Farber received his medical degree from Harvard Medical School and bachelor's degree from Brown University. He completed his residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at Southern Illinois School of Medicine. Dr. Farber is a member of numerous national and regional medical and surgical societies.

Surgeon-in-Chief
Boston Medical Center


Professor
Boston University Chobanian & Avedisian School of Medicine
Surgery
Vascular and Endovascular Surgery

Associate Chief Medical Officer for Surgical Services
Boston Medical Center


Professor
Boston University Chobanian & Avedisian School of Medicine
Radiology
Vascular & Interventional

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research




Impact of Biological, Clinical, and Social Determinants on Trauma and Trauma Outcomes
07/01/2022 - 06/30/2027 (PI)
NIH/National Institute of General Medical Sciences
5T32GM086308-14

A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols
05/01/2012 - 12/31/2015 (PI)
Grifols Inc.


A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm^2 to <= 36 cm^2
10/15/2013 - 08/30/2015 (PI)
HealthPoint Limited


A Non-Interventional Safety Study Providing 12 Months Follow-Up from First Exposure to HP802-247 in Subjects with Venous Leg Ulcer
05/01/2012 - 04/30/2015 (PI)
HealthPoint Limited


Observational Study of Tissue Plasminogen Activator Used for Catheter Directed Thrombolysis in Patients with Acute Lower Extremety Native Artery or Bypass Graft Occlusion
01/27/2014 - 01/26/2015 (PI)
Grifols Inc.


A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
05/01/2012 - 04/30/2014 (PI)
HealthPoint Limited


Vital Access Venous Window Needle Guide for salvage of AV Fistulae (SAVE) Trial
08/15/2012 - 08/14/2013 (PI)
Vital Access Corp


IN-BALANCE VLU (Inflammation, Bacteria, and Angiogenesis effects in launching venous leg ulcer healing: a clinical evaluation)
08/01/2012 - 07/31/2013 (PI)
Celleration, Inc.


A Phase 2 randomized open label study to evaluate the effects of different intra-thrombus infusion regiments of plasmin humun compared to placebo
08/01/2011 - 07/31/2012 (PI)
Talecris Pharmaceuticals


A Phase 2 randomized open label study to evaluate the effects of different intra-thrombus infusion regiments of plasmin humun compared to placebo
08/01/2011 - 07/31/2012 (PI)
Talecris Pharmaceuticals


Showing 10 of 17 results. Show All Results

Peripheral Bypass Trial for Completion Control
11/08/2024 - 11/07/2027 (PI)
Medistim ASA


Best Endovascular vs. Best Surgical Therapy in Patients with Critical Limb Ischemia (Best-CLI)
09/01/2022 - 02/28/2027 (Subcontract PI)
PI: Alik Farber, MD
Brigham and Womens Hospital Novo Nordisk Fdn


Assessment of Wound Closure Comparing Synthetic Hybrid- Scale Fiber Matrix with Lyophilized Acellular Fish Skin in Treating Diabetic Foot Ulcers (DFU) and with Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU)
10/12/2022 - 07/29/2025 (PI)
Acera Surgical Inc.


A multi-center prospective study to evaluate the safety and effectiveness of the VasQ external suppo
11/01/2017 - 04/30/2025 (PI)
Laminate Medical Technologies Inc.


LF-CA-PR-53-PROMISE III Trial
12/09/2022 - 10/31/2024 (PI)
LimFlow Inc


A Pivotal Study to Investigate the Safety and Effectiveness of the Limflow System for the…
12/11/2019 - 10/31/2024 (PI)
LimFlow Inc


Novonordisk-NN9535-4533
09/14/2021 - 09/14/2024 (PI)
Novo Nordisk


A comparative evaluation of a marine polysaccharide dressing and a carboxymethylcellulose dressing on subjects with lower extremity venous ulcerss
10/14/2020 - 10/14/2023 (PI)
Medline Industries LLC


Natural Progression of High-Risk Chronic Limb-Threatening Ischemia. The CLariTI Study.
03/25/2021 - 08/31/2023 (PI)
LimFlow Inc


A multicenter, prospective, randomized, placebo controlled, double blind study performed to…
09/24/2019 - 08/31/2023 (PI)
MediWound Ltd.


Showing 10 of 20 results. Show All Results

Title

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Alonso A, Smith S, Kang H, Patel A, Bui K, Tran A, Maaneb de Macedo K, Kalish J, Farber A, King E, Siracuse JJ, Janeway MG. Discordant recommended postoperative discharge rehabilitation among patients who undergo a major lower extremity amputation. J Vasc Surg. 2026 Feb 16.View Related Profiles. PMID: 41707832
     
  2. Decker JW, BaniHani D, HonShideler C, Lotfollahzadeh S, Wu Wong DJ, Farber A, Siracuse JJ, Idrees N, Dember L, Bader M, Ganguli S, Kolachalama V, Shazly T, Chitalia VC. Intravascular Ultrasound is More Accurate Than Angiography in Arteriovenous Vascular Access Lesions. Kidney360. 2026 Feb 13.View Related Profiles. PMID: 41686504
     
  3. Brooke BS, Doros G, Venermo M, Siracuse JJ, Abou-Zamzam AM, Dosluoglu HH, Motaganahalli RL, Menard MT, Farber A, Conte MS. Early Improvement in Wound, Ischaemia, and foot Infection (WIfI) Ischaemia Grade Lowers Risk of Major Amputation following Revascularisation for Chronic Limb Threatening Ischaemia. Eur J Vasc Endovasc Surg. 2026 Feb 02.View Related Profiles. PMID: 41638549
     
  4. Hicks CW, Farber A, Doros G, Kinlay S, Powell RJ, Strong MB, Rosenfield K, Aridi H, Motaganahalli R, Barleben A, Siracuse JJ, Azene E, Malas M, Conte MS, Zayed M, Menard MT. Atherectomy Is Not Associated With Improved Limb-Based Outcomes Among Patients in the BEST-CLI Trial Undergoing Endovascular Revascularization. JACC Cardiovasc Interv. 2026 Jan 12; 19(1):96-107.View Related Profiles. PMID: 41534992; PMCID: PMC12810858; DOI: 10.1016/j.jcin.2025.10.065;
     
  5. Cheng TW, Farber A, Haqqani M, King EG, Talutis SD, Alonso A, Maaneb de Macedo KA, Hicks CW, Malas MB, Rybin D, Siracuse JJ. Outcomes after infrainguinal interventions for intermittent claudication in patients with end-stage renal disease are poor. J Vasc Surg. 2026 Apr; 83(4):1136-1145.View Related Profiles. PMID: 41423025
     
  6. Tan TW, Dansey KD, Farber A, Doros G, Menard MT, Rosenfield K, Conte MS, Venermo M, Kolh P, Strong MB, Singh N. High rates of nonindex limb amputation in the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial. J Vasc Surg. 2026 Mar; 83(3):905-913.View Related Profiles. PMID: 41242623; PMCID: PMC12735402; DOI: 10.1016/j.jvs.2025.11.009;
     
  7. Alabi O, Doros G, Hamouda M, Conte MS, Farber A, Kirksey L, Menard MT, Kernodle A, McGinigle K, Moreira C, Rosenfield K, Strong MB, Ulloa JG, Kaufman JA, Malas M, Rowe VL. Examination of Race and Ethnicity After Revascularization in the BEST-CLI Trial. Ann Surg. 2025 Nov 11.View Related Profiles. PMID: 41214473
     
  8. Powell RJ, Menard MT, Rosenfield K, Strong MB, Conte MS, Doros G, Ezra A, Garg N, Mena-Hurtado C, Lane JS, Shah SK, Venermo M, Zhou W, Farber A. Influence of specialty on endovascular practice patterns and outcomes in the BEST-CLI Trial. J Vasc Surg. 2025 Nov 06.View Related Profiles. PMID: 41205838
     
  9. Shishehbor MH, Dua A, Powell RJ, Montero-Baker MF, Martínez-Trabal JL, Bunte MC, Lee AC, Mills JL, Farber A, Clair DG. Two-Year Outcomes after Transcatheter Arterialization of the Deep Veins. N Engl J Med. 2025 Oct 30; 393(17):1751-1753. PMID: 41160827; DOI: 10.1056/NEJMc2507935;
     
  10. Zhou CW, Hoch M, Freeman NLB, Menard MT, Farber A, Chung J, Kosorok MR, McGinigle KL. Using precision medicine methods to identify disease stages for chronic limb-threatening ischemia in participants of the BEST-CLI trial. J Vasc Surg. 2026 Mar; 83(3):784-792.e1. PMID: 41167383; PMCID: PMC12927038; DOI: 10.1016/j.jvs.2025.10.029;
     
Showing 10 of 418 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 417 publications over 28 distinct years, with a maximum of 44 publications in 2025

YearPublications
19921
19931
19992
20011
20022
20033
20044
20051
20073
20082
20096
20104
201112
20129
201319
201415
201521
201641
201738
201840
201925
202036
202119
202214
202323
202427
202544
20264

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
Contact for Mentoring:

85 E. Concord St.
Boston MA 02118
Google Map


Farber's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_